Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ceteri Capital is an operator-led investment platform based in Los Angeles, founded in 2022. The firm focuses on venture capital investments, particularly in misunderstood markets within the healthcare and financial services sectors. Ceteri Capital distinguishes itself by leveraging operational expertise and networks to support its portfolio companies, providing not just capital but also strategic partnerships and operational guidance.
The firm operates globally, with a specific emphasis on North America and the United States. Ceteri Capital's approach is relationship-driven, aiming to build strong connections with founders to facilitate both early-stage access and late-stage strategic partnerships. The firm has a singular portfolio company, Galileo, which reflects its targeted investment strategy.
Ceteri Capital primarily invests in the healthcare and financial technology sectors, targeting seed-stage and Series B+ opportunities. The firm utilizes its operator-led model to provide unique insights and access to its portfolio companies, which is particularly beneficial in misunderstood markets. Ceteri Capital seeks to establish strong relationships with founders, offering support that extends beyond financial investment.
The firm emphasizes the importance of operational support and strategic partnerships, which are integral to its investment thesis. Ceteri Capital aims to leverage its on-the-ground networks to provide early access to opportunities and facilitate corporate partnerships that can enhance the growth trajectory of its portfolio companies.
Ceteri Capital's notable portfolio company is Galileo, a healthcare technology platform that enables comprehensive clinical care through mobile and online services. Ceteri made a Series D investment in Galileo in December 2022. This investment highlights Ceteri's focus on healthcare technology and its commitment to supporting companies that provide innovative solutions in this sector.
Currently, no additional verified portfolio companies have been disclosed by Ceteri Capital. However, the firm’s founder, Christopher Hill, previously led investments in notable companies such as Alto Pharmacy, Spotlight Therapeutics, and Cortex Health while at a family office. These past experiences inform Ceteri's investment strategy, although they are not officially part of Ceteri's portfolio.
Christopher Hill - Founder and Managing Partner. Christopher has a background in venture capital and previously worked at a family office with approximately USD 150 million in allocated capital. He has led investments in companies such as Alto Pharmacy, Galileo Health, Spotlight Therapeutics, and Cortex Health. His expertise lies in healthcare and financial services, making him well-suited to guide Ceteri Capital's investment strategy.
To pitch Ceteri Capital, founders should visit their website at cetericapital.com. It is recommended to include a detailed deck that outlines the business model, market opportunity, and how the firm’s operational expertise can add value. Founders should expect a response time that varies based on the volume of submissions, and warm introductions may enhance the chances of engagement.
In December 2022, Ceteri Capital made a Series D investment in Galileo, a healthcare technology platform. This investment marks a significant milestone for the firm, showcasing its commitment to supporting innovative solutions in the healthcare sector.
What are Ceteri Capital's investment criteria?
Ceteri Capital focuses on seed-stage and Series B+ investments in the healthcare and fintech sectors. The firm looks for companies that operate in misunderstood markets and can benefit from operational support and strategic partnerships.
How can I pitch to Ceteri Capital?
What makes Ceteri Capital different from other VC firms?
Ceteri Capital distinguishes itself with its operator-led approach, which combines investment with hands-on operational guidance. This model allows the firm to provide unique insights and access to its portfolio companies, enhancing their growth potential.
What is Ceteri Capital's geographic scope?
The firm operates globally, with a primary focus on North America and the United States. This broad geographic scope allows Ceteri to identify and invest in promising startups across various markets.
What is the typical check size for investments?
Specific check sizes have not been disclosed. However, Ceteri Capital targets seed-stage and Series B+ investments, which typically range from hundreds of thousands to several million dollars, depending on the stage and needs of the company.
What kind of support can portfolio companies expect?
Portfolio companies can expect operational support, strategic partnerships, and access to Ceteri Capital's networks. The firm emphasizes building strong relationships with founders to facilitate growth and success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.